Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 6, No 4 (2010) EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA Abstract  similar documents
P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev
"... .2 to 1.3±0.07 nM/ml; p<0.001) unlike reception of oil solution of lycopene. Conclusion: Lactolycopene ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... to the first and to control groups. In the second group LF increased from 223.8±56.2 to 734±90.9 мs2 (p<0.001 ..."
 
Vol 5, No 6 (2009) INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS Abstract  similar documents
A. A. Usanova, A. A. Aleksandrovsky, A. V. Zorkina, O. M. Kiselеv
"... балл ЭКГ-изменений возрастал (с 1,31±0,24 до 3,38±0,26, p<0,001). Статистически значимое снижение ..."
 
Vol 12, No 2 (2016) LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta
"... , and after 1 month while taking rosuvastatin – 4.89±0.81 mmol/l (p<0.001). The change of TC level was -22% (p ..."
 
Vol 6, No 1 (2010) EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS Abstract  PDF (Eng)  similar documents
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova
"... % (p<0.001), efficiency of heart work by 12% (p<0.05), decrease in frequency of angina attacks by 51 ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... levels of serum transaminases are detected. To expand the use of statins in these patients, a scheme ..."
 
Vol 10, No 5 (2014) EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova
"... Aim. To study the efficacy of rosuvastatin in dyslipidemia correction in patients after Q-wave ..."
 
Vol 13, No 5 (2017) IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? Abstract  similar documents
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
"... .14 vs 1.27 in the control group (p<0.001). In the main group, adherence to antihypertensive therapy ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... .3 mmol/L and 2.3 mmol/L, respectively (p<0.001). Deterioration in the dynamics of alanine ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... ; p<0.001) after 6 months was found in patients treated with lipid-lowering therapy in combination ..."
 
Vol 11, No 4 (2015) TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE Abstract  similar documents
V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova
"... of dyslipidemia, or pay more attention to secondary prevention of cardiovascular diseases. Aim. To analyze ..."
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
"... with hypertension and dyslipidemia. Material and methods. Analysis of the medical data of patients treated ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... for the treatment of dyslipidemia issued by European Society of Cardiology and European Atherosclerosis Society ..."
 
Vol 7, No 1 (2011) DYSLIPIDEMIA FEATURES IN CHILDREN Abstract  similar documents
T. I. Turkinа, M. Yu. Shcherbakova
"... Contemporary scientific and practical data about various lipid metabolism disorders (dyslipidemia ..."
 
Vol 9, No 2 (2013) PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET Abstract  similar documents
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova
"... , dyslipidemia, arterial hypertension Ration Pharmacother Cardiol 2013;9(2):152-157 *Автор, ответственный за ..."
 
Vol 11, No 3 (2015) EVALUATION OF THE REGULARITY OF ANTIHYPERTENSIVE DRUGS USAGE AS A COMPONENT OF TREATMENT ADHERENCE IN OUTPATIENTS OF A SPECIALIZED CARDIOLOGY CENTER Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S.B B. Fitilev
"... -control in home settings (OR=2.5), unable to get drugs under the medicine assistance scheme (OR=1 ..."
 
Vol 14, No 1 (2018) THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA Abstract  PDF (Eng)  similar documents
S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina
"... groups of men and women (p<0.01). Over the three decades, the total cholesterol concentration has ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... .8±8.4 and -30.4±12.8/18.7±8 mm Hg for groups 1 and 2, respectively , p<0.001 for the both groups ..."
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... in 3 years. Material and methods. Patients with dyslipidemia (113 patients in 2011 and 100 patients ..."
 
Vol 5, No 4 (2009) METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER Abstract  similar documents
B. N. Garifullin, A. N. Zakirova, F. S. Zarudij
"... schemes for carvedilol in patients with acute MI are discussed. ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... , triglyceride (p<0.001) and significant increase in high-density lipoprotein cholesterol (p<0.001) when compared ..."
 
Vol 4, No 5 (2008) INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS Abstract  similar documents
V. V. Fomin
"... resistance syndrome, diabetes type 2, dyslipidemia, obesity. Approaches to prevention of kidney disorder ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... with dyslipidemia were enrolled into non-randomized open-label study, of which 149 patients were assigned to a group ..."
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... .3%, "probable" – 18.1%. Patients with definite FH diagnosis showed higher level of TCh (p<0.001), LDL ..."
 
Vol 12, No 3 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 2 Abstract  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... .3 40.9±8.7 61.1±8.5 <0.001 Men, % / Мужчин, % 34% 26.4 41.5 <0.001 Smoking, % / Курение, % 19.1 20.8 17 ..."
 
Vol 14, No 3 (2018) RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME Abstract  similar documents
V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev
"... , hyperglycemia – in 39%, diabetes – in 36%, dyslipidemia – in 80% of patients. The EEC in MS patients (1.59±0 ..."
 
Vol 1, No 2 (2005) ASSESSMENT OF INFLUENCE OF BETAGISTIN IN COMBINATION WITH ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE AND NEUROLOGICAL STATUS OF PATIENTS WITH STABLE ARTERIAL HYPERTENSION AND DIZZINESS Abstract  similar documents
G. V. Andreeva, S. Y. Martsevich, V. M. Gorbunov, O. A. Melnikov, V. P. Voronina, I. P. Zhigareva
"... with both schemes of treatment resulted in comparable decrease in BP level. Treatment with both regimes ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... has become one of the strategic directions. First-line agents in the treatment of dyslipidemia ..."
 
Vol 14, No 2 (2018) CHANGE IN THE FUNCTIONAL STATE OF ERYTHROCYTES AS A COMPONENT OF MICROCIRCULATORY DISORDERS IN METABOLIC SYNDROME Abstract  similar documents
V. I. Podzolkov, T. V. Koroleva, A. Е. Bragina, M. G. Kudryavtseva, N. A. Druzhinina, M. V. Pisarev
"... .64Ѓ}0.03×107, respectively, p<0.001). Significant negative correlations between EEC and age (r=-0 ..."
 
Vol 15, No 3 (2019) Effect of Hyperglycemia on the Total Surface Charge of the Erythrocyte Membrane in Patients with Metabolic Syndrome Abstract  similar documents
V. I. Podzolkov, T. V. Koroleva, M. G. Kudryavtseva
"... .58±0.05×107 and 1.64±0.03×107, respectively; p=0.001)., Significant negative correlations between SCEM ..."
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... resistance, obesity, dyslipidemia is also covered. The evidence base for the use of telmisartan as a drug ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... with the control group women had higher values of minimum (52.3±0.4 vs 47.5±0.4; p<0.001) and mean (78.5±0.5 vs 75 ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
"... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..."
 
Vol 13, No 3 (2017) TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 Abstract  similar documents
O. M. Drapkina, A. S. Luishuta
"... and dyslipidemia in real clinical practice makes it possible to evaluate the potential contribution ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... , high risk of cardiovascular disease, dyslipidemia. Ration Pharmacother Cardiol 2015;11(2):167-169 ..."
 
Vol 11, No 6 (2015) RESULTS OF TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DATA OF A RETROSPECTIVE, SINGLE-CENTER STUDY (IN-HOSPITAL PERIOD) Abstract  similar documents
D. B. Nemick, G. V. Matyushin, A. V. Protopopov, S. A. Ustyugov, A. V. Shulmin
"... coronary artery lesions in both PPCI and PIS subgroups (p<0.001). This has determined more frequent ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... (compensated) of LV remodeling increased by 18% (p<0.001) in group A2, and by 6%, (p=0.03) in group A1. After ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... therapy in high doses is discussed in patients with IHD and dyslipidemia. Atorvastatin in high doses ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... (p<0.001), they were more often diagnosed with left ventricular aneurysm (p=0.001), chronic kidney ..."
 
Vol 13, No 3 (2017) ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) Abstract  PDF (Eng)  similar documents
O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov
"... .4% vs 44.3%; p<0.001), especially of abdominal type and elevated triglycerides (1.3±0.9 vs 1.8±1.1 mmol ..."
 
Vol 12, No 4 (2016) Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk Abstract  similar documents
O. M. Drapkina, O. N. Korneeva
"... syndrome and etc.). The relationship of NAFLD with atherosclerosis, dyslipidemia, features of bile acids ..."
 
Vol 5, No 2 (2009) COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
"... systolic and diastolic blood pressure (SBP, DBP) reduced in both groups р<0,0001. There were ..."
 
Vol 13, No 1 (2017) QUALITY OF LIFE, CLINICAL AND BIOCHEMICAL PARAMETERS IN HYPERTENSIVE PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
E. B. Akhmedova, B. U. Mardanov, K. K. Badeynikova, M. N. Mamedov
"... severe dyslipidemia. Conclusion. In patients with HT concomitant DM and COPD contribute to the quality ..."
 
Vol 9, No 4 (2013) EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY Abstract  similar documents
E. V. Goncharova, A. V. Govorin
"... with cardiomyopathy. Flow rate rapid filling re- duced by 27.1% compared with this in control (p<0.001), and flow rate ..."
 
Vol 5, No 5 (2009) EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev
"... -diastolic dimension (p<0,001), end-systolic dimension (p<0,001), left atrium (p=0,004), end-diastolic vol ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE Abstract  similar documents
G. I. Nechaeva, E. N. Loginova
"... reception and «School of the hypertensive patient») with these of the carvedilol monotherapy in young ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
"... reception and «School of the hypertensive patient») with these of the carvedilol monotherapy in young ..."
 
Vol 7, No 2 (2011) EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY Abstract  similar documents
A. G. Avtandilov, I. I. Esenova, S. L. Petrosov
"... . Key words: arterial hypertension, obesity, sympathetic over activity, insulin resistance, dyslipidemia ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... disease and/or with elevated transaminases. Keywords: statins, dyslipidemia, high risk of cardiovascular ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... at the start visit according to the randomization scheme. The first study drug course was 3 weeks, then next ..."
 
Vol 10, No 3 (2014) EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... <0.001) were revealed. The right ventricle increased in size with the impairment of its diastolic ..."
 
Vol 12, No 1 (2016) Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease Abstract  PDF (Eng)  similar documents
E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova
"... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..."
 
Vol 12, No 6 (2016) EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... myocardial mass (from 170 [225.5;213.5] to 159 [146;167] g; p<0.001), and size of the left atrium (LA; from ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... otherwise specified *p<0.05, **p<0.01, ***p<0.001 compared to the data in 2011; †p<0.05, ††p<0.01, †††p<0.001 ..."
 
Vol 7, No 5 (2011) EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY Abstract  similar documents
V. M. Provotorov, S. A. Avdeeva
"... increase in hemoglobin (+12.5%; p<0.001) and hematocrit (+5.8%; p<0.001) levels, as well as increase in red ..."
 
Vol 15, No 3 (2019) Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... valve in patients of groups 1 and 2 was lower than in the control by 15% and 17%, respectively (p<0.001 ..."
 
Vol 10, No 6 (2014) VALIDATION OF THE MACNEW QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ISHEMIC HEART DISEASE Abstract  PDF (Eng)  similar documents
N. V. Pogosova, A. A. Kursakov, I. H. Boycharov, S. Höfer, N. Oldridge
"... was established in the total sample of ICD patients (0.949; p<0.01). Factor analysis in general substantiated ..."
 
Vol 8, No 5 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpigina
"... .9 (р<0.01) for all items of EF questionnaire and - 0.73±2.7 (р<0.05) for the 1-5,15 items of EF ..."
 
Vol 6, No 5 (2010) INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  PDF (Eng)  similar documents
E. N. Golovenko, D. A. Napalkov, V. A. Sulimov
"... (FC) III-IV than in those with CHF of FC I-II (p<0.001). Negative correlation was revealed between TrI ..."
 
Vol 13, No 4 (2017) COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina
"... volume (p<0.01),right ventricle anterior-posterior dimension (p<0.001), right atrium volume (p<0.01 ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... simvastatin TC decreased from 6.4±0.8 to 4.4±0.6 mmol/l (p<0.001) and from 6.0±0.7 to 4.1±0.7 mmol/l (p<0.001 ..."
 
Vol 15, No 2 (2019) Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... - 0.9 [0.8;1.31 ], in the 2nd group - 0.8 [0.78; 1.2] with a control value of 1.6 [1.2;1.94] (p<0.001 ..."
 
Vol 6, No 4 (2010) COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov
"... reduction from 98.6±2.5 to 58.6±3.5 bt/min (р<0.001) was found with the 24 hour electrocardiogram-monitoring ..."
 
Vol 11, No 3 (2015) THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION Abstract  similar documents
I. L. Tepoyan, D. V. Nebieridze, I. A. Skripnikova, A. S. Safaryan, V. A. Vygodin, V. E. Novikov, L. M. Murashko
"... increase in BMD in the spine according to the T-test from -1.7±0.4 SD to -1.4±0.53 SD (p<0.001), while ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... density cholesterol (LDC) by 52.4% (p<0.001) was found after 24 weeks in Group 1. Achieving the target LDC ..."
 
Vol 2, No 4 (2006) REPORT ON OPEN MULTICENTRAL RESEARCH PROGRAM “PRIORITY” IN CLINICAL PRACTICE. (PEKTROL – QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA PECTORIS TREATED WITH ISOSORBIDE-5-MONONITRATE IN LONG-ACTING PRESENTATION) Abstract  similar documents
Yu. A. Karpov
"... protocol. The treatment with ISMN reduced the frequency and duration of angina attacks (p<0,001 ..."
 
Vol 7, No 6 (2011) EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS Abstract  similar documents
V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova
"... Hg; p<0.001; dyastolic BP decreased from 90 (87;93) to 80 (77;84) mm Hg; p<0.001 ..."
 
Vol 13, No 5 (2017) COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES Abstract  similar documents
A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash
"... and more often had excess body weight (p<0.001). The majority of current smokers were males (p<0.001 ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... ) and LDL cholesterol reduced on 25,2% and 33,6% (p<0,001), respectively. Next 6 weeks of therapy ..."
 
Vol 15, No 1 (2019) Prognostic Value of ECG in Patients with Pulmonary Embolism Abstract  similar documents
I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov
"... -complete right bundle branch block (RBBB) (16.3 vs 37.9%; p=0.001), ST segment elevation in lead III (9 ..."
 
Vol 2, No 1 (2006) ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE Abstract  similar documents
R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov
"... in 24 hrs. (from 141.9±1.9 to 128.6±0.8 mmHg, p<0.001), in daytime (from 146.8±2.6 to 135.8±1.0 mmHg, p ..."
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... .05). Group 4: the average CHF class decreased by 41.4% (p<0.001), EF increased by 32.8% (p<0.001). Conclusion ..."
 
Vol 3, No 5 (2007) RENAL HEMODYNAMICS AND GLOMERULAR FILTRATION RATE IN MEN AND WOMEN WITH ARTERIAL HYPERTENSION AT THE AGE OF 40-60 YEARS Abstract  similar documents
I. G. Fomina, A. E. Bragina, N. E. Gaydamakina, J. N. Salimzhanova
"... показатели почечного кровотока и ОСКФ были достоверно ниже, чем у мужчин (p<0,001). В контрольной группе ..."
 
Vol 8, No 6 (2012) THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY Abstract  similar documents
K. M. Dzeranova, A. G. Avtandilov, N. V. Vertkina
"... product elevated from 1.86±0.05 to 2.06±0.05 units (p<0.001); threshold power increased - relative ..."
 
Vol 7, No 6 (2011) MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS Abstract  similar documents
N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya
"... associations of MAC presence with symptomatic atherosclerotic peripheral arterial disease (p <0.001; ß=0 ..."
 
Vol 13, No 3 (2017) ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... , and reduced mean blood-flow velocity in the portal vein (p<0.001). According to the DEchoCG data, in patients ..."
 
Vol 5, No 4 (2009) COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS Abstract  PDF (Eng)  similar documents
N. A. Karoli, A. P. Rebrov
"... (r=0,33, p<0,05), left ventricle ejection fraction (r=-0,40, p<0,01) was found. Conclusion. COPD ..."
 
Vol 8, No 2 (2012) SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS Abstract  similar documents
I. S. Dzherieva, N. I. Volkova, S. I. Rapoport
"... .3%, respectively; p<0.001) and glucose metabolism disorders rates (19.0 vs. 10.6%, respectively; p<0.001) were also ..."
 
Vol 6, No 1 (2010) ACTOVEGIN INFLUENCE ON METABOLIC AND VASOMOTOR FUNCTION OF MICROVASCULAR ENDOTHELIAL OF HUMAN SKIN Abstract  similar documents
A. A. Fedorovich, A. N. Rogoza, E. M. Kanisheva, S. A. Boytsov
"... increased in maximal amplitude endothelial rhythm (at a frequency of 0.01 Hz) by 76% (p<0,001 ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS Abstract  similar documents
O. L. Barbarash, M. V. Zykov
"... systolic and diastоlic BP was reduced by 36 and 17 mmHg respectively (рem0,001/em for both), and target BP ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... of group C and 95,5% of group M reached target levels of BP. Significant reduction of glucose (pem0,01/em ..."
 
Vol 12, No 3 (2016) ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS Abstract  PDF (Eng)  similar documents
R. A. Gajfulin, A. N. Sumin, O. G. Arhipov
"... correlated with age: At (p=0.004); Et/At (p=em0.001/em); Vpt (p=0.002) and e't/a't ratio (p=0.004). Conclusion ..."
 
Vol 7, No 6 (2011) DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL Abstract  similar documents
E. I. Tarlovskaya, D. A. Suvorova, A. A. Sobolev
"... =0.826; p=0.em0001/em), HT duration (r=0.498; p=0.em0001/em), BPs level (r=0.466; p=em0.001/em), microalbuminuria ..."
 
Vol 1, No 3 (2005) COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS Abstract  similar documents
T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin
"... em0,001/em) and diastolic BP – на 12,9% (рem0,001/em). CA reduced systolic BP by 17,9% (р0,em0001/em ..."
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... noticeable in women up to 50 years old (T allele – OR 0,21; C allele – OR 4,57, p=em0,001/em). Conclusion ..."
 
Vol 14, No 5 (2018) Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha in Patients with Early Psoriatic Arthritis Abstract  similar documents
E. I. Markelova, D. S. Novikova, T. V. Korotaeva, E. Yu. Loginova
"... values: DAS decreased from 4.6 (2.9; 1.9) to 1.6 (1.3; 1.9), p=em0,001/em; HAQ from 0.93 (0.81; 1.31) to 0 ..."
 
Vol 12, No 3 (2016) EFFECT OF GENDER DIFFERENCES ON THE EFFICACY AND SAFETY OF REPERFUSION THERAPY OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (DATA OF RETROSPECTIVE SINGLE-CENTER STUDY – HOSPITAL PERIOD) Abstract  PDF (Eng)  similar documents
D. B. Nemik, G. V. Matyushin, A. V. Protopopov, A. V. Shulmin, S. A. Ustyugov
"... .1% in whole (5.1% at pPCI and 0.8% at FIS), respectively (pem0.001/em). The probability of lethal outcome in women ..."
 
Vol 15, No 1 (2019) Improving the cognitive functions in the middle-aged patients with essential arterial hypertension after the treatment with amlodipine/valsartan single-pill combination Abstract  similar documents
O. D. Ostroumova, E. V. Borisova, A. I. Kochetkov, T. M. Ostroumova, O. V. Bondarec
"... , diastolic and pulse BP significantly decreased after the treatment with A/V SPC (pem0.001/em for systolic ..."
 
Vol 12, No 2 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 1 Abstract  PDF (Eng)  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... plaques: r=0.46 (рem0.001/em) in the younger group and r=0.47 (рem0.001/em) in the older one. We didn’t find any ..."
 
Vol 9, No 6 (2013) EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE Abstract  similar documents
T. V. Pinchuk, Y. N. Fedulaev, G. A. Khairetdinova, A. A. Kozina, V. N. Ryzhenkov, N. M. Ahmedzhanov
"... early diastolic left ventricular filling velocity) value by 14.1% (pem0.001/em) and E/A (where A - peak left ..."
 
Vol 5, No 1 (2009) EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. M. Gorbunov, E. J. Fedorova, A. D. Deev, E. V. Platonova, O. J. Isaikina
"... ,1 mm Hg (pem0,001/em) and with morning taking – to 131,8±1,6/79,2±1,1 mm Hg (pem0,001/em). Evening ramipril ..."
 
Vol 6, No 5 (2010) THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets
"... , respectively (pem0.001/em). Episodes of sinus tachycardia decreased on 52.3% (pem0.001/em) and 48,5% (pem0.01/em ..."
 
Vol 7, No 5 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva
"... decreased 2 hours after nebivolol intake both single one and after 30 days of treatment (pem0.001/em). Duration ..."
 
Vol 14, No 3 (2018) ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
D. B. Nemik, G. V. Matyushin, S. A. Ustyugov
"... (38.5% vs 20.6%, pem0.001/em), fewer patients to whom the FIS was applied (33.3% vs 45.7%; p=0 ..."
 
Vol 4, No 2 (2008) MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY Abstract  similar documents
L. G. Voronkov, A. A. I.Shkurat, E. A. Lutsak
"... phase was observed (from 8,6+0,8 to 14,4+0,9%, рem0,001/em). After placebo infusion BA diameter did ..."
 
Vol 7, No 3 (2011) COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY Abstract  similar documents
O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko
"... and daytime systolic BP (SBP) by 17.2% (p0.em0001/em), nighttime SBP - by 22.5% (p0.em0001/em), 24-hour and daytime ..."
 
Vol 13, No 3 (2017) GENETIC ASPECTS OF MODIFIABLE RISK FACTORS ASSOCIATED WITH ARTERIAL HYPERTENSION BY THE EXAMPLE OF THE INDIGENOUS POPULATION OF MOUNTAIN SHORIYA Abstract  similar documents
T. A. Mulerova, G. V. Artamonova, M. I. Voevoda, O. V. Gruzdeva, M. Yu. Ogarkov, O. L. Barbarash
"... -betacholesterolemia, obesity and abdominal obesity were 11.20 (р=0.018); 4.65 (р=em0.001/em); 2.31 (р=0.031) and 1.83 (р=0 ..."
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... ,744-0,927], р=em0,001/em), ИМ (ОШ:0,811 [95% ДИ 0,748-0,879], рem0,001/em), инсульта (ОШ: 0,796 [95% ДИ 0,682-0 ..."
 
Vol 8, No 5 (2012) ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE Abstract  similar documents
M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina
"... (p=0.016). More significant reduction in average daily and night systolic and diastolic BP (p=em0.001/em ..."
 
1 - 100 of 795 Items 1 2 3 4 5 6 7 8 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)